These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis. Lepper AW; Elleman TC; Hoyne PA; Lehrbach PR; Atwell JL; Schwartzkoff CL; Egerton JR; Tennent JM Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935 [TBL] [Abstract][Full Text] [Related]
3. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364 [TBL] [Abstract][Full Text] [Related]
4. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. Lepper AW; Moore LJ; Atwell JL; Tennent JM Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693 [TBL] [Abstract][Full Text] [Related]
5. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis. Lepper AW Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257 [TBL] [Abstract][Full Text] [Related]
6. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine. Angelos JA; Bonifacio RG; Ball LM; Hess JF Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049 [TBL] [Abstract][Full Text] [Related]
7. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis. Angelos JA; Gohary KG; Ball LM; Hess JF Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196 [TBL] [Abstract][Full Text] [Related]
8. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine. Angelos JA; Hess JF; George LW Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703 [TBL] [Abstract][Full Text] [Related]
9. Estimation of fimbrial vaccine effectiveness in protection against keratoconjunctivitis infectiosa in calves considering different routes of introducing vaccine antigene. Misiura M Arch Vet Pol; 1994; 34(3-4):177-86. PubMed ID: 8891172 [TBL] [Abstract][Full Text] [Related]
10. Keratoconjunctivitis infectiosa in calves--attempt at elimination by active immunization. Misiura M Arch Vet Pol; 1994; 34(3-4):187-94. PubMed ID: 8891173 [TBL] [Abstract][Full Text] [Related]
11. Infectious bovine keratoconjunctivitis: enhancement of Moraxella bovis pili immunogenicity with diphtheria-tetanus toxoids and pertussis vaccine. Pugh GW; Kopecky KE; McDonald TJ Am J Vet Res; 1984 Apr; 45(4):661-5. PubMed ID: 6145379 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens. Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421 [TBL] [Abstract][Full Text] [Related]
13. Reproduction of bovine keratoconjunctivitis with a purified haemolytic and cytotoxic fraction of Moraxella bovis. Beard MK; Moore LJ Vet Microbiol; 1994 Sep; 42(1):15-33. PubMed ID: 7839582 [TBL] [Abstract][Full Text] [Related]
14. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells. Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis. George LW; Borrowman AJ; Angelos JA Am J Vet Res; 2005 Jan; 66(1):136-42. PubMed ID: 15691049 [TBL] [Abstract][Full Text] [Related]
16. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA. McConnel CS; Shum L; Gleeson BL; House JK Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984 [TBL] [Abstract][Full Text] [Related]
17. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants. Ruehl WW; Marrs CF; George L; Banks SJ; Schoolnik GK Am J Vet Res; 1993 Feb; 54(2):248-53. PubMed ID: 8094276 [TBL] [Abstract][Full Text] [Related]
18. Randomized blinded controlled trial to assess the association between a commercial vaccine against Moraxella bovis and the cumulative incidence of infectious bovine keratoconjunctivitis in beef calves. Cullen JN; Engelken TJ; Cooper V; O'Connor AM J Am Vet Med Assoc; 2017 Aug; 251(3):345-351. PubMed ID: 28703672 [TBL] [Abstract][Full Text] [Related]
19. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines. Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697 [TBL] [Abstract][Full Text] [Related]